News Detail
Orion, Bayer prostate cancer drug gets FDA approval
The compound was approved under the FDA Priority Review designation, which is reserved for medicines that may provide significant improvements in the safety or effectiveness of the treatment for serious conditions," Orion said.
Chemxpert Demo Video
Dataset Sample
Chemical Name |
Synonyms |
Molecular Formula |
Molecular Weight |
|---|
Dataset Sample
| Product Name | Innovator |
|---|
Dataset Sample
| Product Name | Market Status |
|---|
Dataset Sample
| Product Name | Indication |
|---|
Dataset Sample
| Product Name | Therapeutic Segment |
|---|
Thank you for your enquiry
Your product will be updated soon in our database